XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Unaudited Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Series A Preferred Stock
Preferred Stock
Series A Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance, preferred stock, outstanding (in shares) at Dec. 31, 2023     0        
Beginning balance at Dec. 31, 2023 $ 337,663   $ 0 $ 45 $ 652,880 $ (345) $ (314,917)
Beginning balance, common stock, outstanding (in shares) at Dec. 31, 2023       45,167,225      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 14,902       14,902    
Stock option exercises (in shares)       36,250      
Stock option exercises 91       91    
Stock issued – on vested RSUs (in shares)       901,413      
Stock issued – on vested RSAs 1     $ 1      
Common stock shares issued (65)       (65)    
Foreign currency translation (192)         (192)  
Unrealized loss on available-for-sale securities (18)         (18)  
Net loss (30,940)           (30,940)
Ending balance, preferred stock, outstanding (in shares) at Jun. 30, 2024     0        
Ending balance at Jun. 30, 2024 321,442   $ 0 $ 46 667,808 (555) (345,857)
Ending balance, common stock, outstanding (in shares) at Jun. 30, 2024       46,104,888      
Beginning balance, preferred stock, outstanding (in shares) at Mar. 31, 2024     0        
Beginning balance at Mar. 31, 2024 333,405   $ 0 $ 46 659,063 (566) (325,138)
Beginning balance, common stock, outstanding (in shares) at Mar. 31, 2024       45,689,583      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 8,719       8,719    
Stock option exercises (in shares)       36,250      
Stock option exercises 91       91    
Stock issued – on vested RSUs (in shares)       379,055      
Stock issued – on vested RSAs 0            
Common stock shares issued (65)       (65)    
Foreign currency translation 11         11  
Net loss (20,719)           (20,719)
Ending balance, preferred stock, outstanding (in shares) at Jun. 30, 2024     0        
Ending balance at Jun. 30, 2024 321,442   $ 0 $ 46 667,808 (555) (345,857)
Ending balance, common stock, outstanding (in shares) at Jun. 30, 2024       46,104,888      
Beginning balance, preferred stock, outstanding (in shares) at Dec. 31, 2024   0 0        
Beginning balance at Dec. 31, 2024 $ 348,909   $ 0 $ 47 683,939 24 (335,101)
Beginning balance, common stock, outstanding (in shares) at Dec. 31, 2024 46,906,765     46,906,765      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation $ 10,012       10,012    
Stock option exercises (in shares) 10,000     10,000      
Stock option exercises $ 18       18    
Stock issued – on vested RSUs (in shares)       715,713      
Stock issued – on vested RSAs 0     $ 1 (1)    
Common stock shares issued for PanTHERA Transaction (in shares)       213,360      
Common stock shares issued for PanTHERA Transaction 4,455       4,455    
Unrealized loss on available-for-sale securities 47         47  
Net loss (16,286)           (16,286)
Ending balance, preferred stock, outstanding (in shares) at Jun. 30, 2025   0 0        
Ending balance at Jun. 30, 2025 $ 347,155   $ 0 $ 48 698,423 71 (351,387)
Ending balance, common stock, outstanding (in shares) at Jun. 30, 2025 47,845,838     47,845,838      
Beginning balance, preferred stock, outstanding (in shares) at Mar. 31, 2025     0        
Beginning balance at Mar. 31, 2025 $ 352,624   $ 0 $ 48 688,092 33 (335,549)
Beginning balance, common stock, outstanding (in shares) at Mar. 31, 2025       47,548,431      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 5,859       5,859    
Stock option exercises (in shares)       10,000      
Stock option exercises 18       18    
Stock issued – on vested RSUs (in shares)       74,047      
Stock issued – on vested RSAs (1)       (1)    
Common stock shares issued for PanTHERA Transaction (in shares)       213,360      
Common stock shares issued for PanTHERA Transaction 4,455       4,455    
Unrealized loss on available-for-sale securities 38         38  
Net loss (15,838)           (15,838)
Ending balance, preferred stock, outstanding (in shares) at Jun. 30, 2025   0 0        
Ending balance at Jun. 30, 2025 $ 347,155   $ 0 $ 48 $ 698,423 $ 71 $ (351,387)
Ending balance, common stock, outstanding (in shares) at Jun. 30, 2025 47,845,838     47,845,838